Cerebral Perfusion Pressure Using Precedex and Other Sedatives

PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Endotracheal IntubationContinuous IV SedationICP Monitoring
Interventions
DRUG

Standard-of-Care plus Dexmedetomidine

Subjects who are treated with dexmedetomidine (Precedex) in addition to the standard of care sedation regiment

OTHER

Standard-of-Care

Subjects who are treated with the standard of care sedation regiment only.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Duke University

OTHER